We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AET
26
DELISTED
Aetna Inc
AET
$28.9M 0.75%
236,833
+187,588
+381% +$21.5M
MJN
27
DELISTED
Mead Johnson Nutrition Company
MJN
$28.7M 0.75%
315,982
+581
+0.2% +$49.2K
YHOO
28
DELISTED
Yahoo Inc
YHOO
$28.5M 0.74%
757,838
-279,786
-27% -$10.3M
ABT icon
29
Abbott
ABT
$175B
$27.6M 0.72%
701,259
+564,323
+412% +$22.5M
INTC icon
30
Intel
INTC
$508B
$27.3M 0.71%
833,277
-1,402,666
-63% -$43.9M
INCY icon
31
Incyte
INCY
$23.2B
$27M 0.7%
338,061
+64,709
+24% +$5.02M
CVX icon
32
Chevron
CVX
$390B
$26.8M 0.7%
255,761
-560
-0.2% -$56.3K
AXP icon
33
American Express
AXP
$233B
$26.8M 0.7%
440,624
-52,060
-11% -$3.3M
SLB icon
34
SLB Ltd
SLB
$70.9B
$26.5M 0.69%
335,053
+57,346
+21% +$4.4M
MO icon
35
Altria Group
MO
$120B
$25.9M 0.67%
375,303
+173,954
+86% +$11.1M
TRV icon
36
Travelers Companies
TRV
$78.7B
$25.6M 0.67%
214,890
-34,003
-14% -$3.85M
TGT icon
37
Target
TGT
$61.1B
$24.9M 0.65%
356,752
+131,395
+58% +$9.8M
ALL icon
38
Allstate
ALL
$65.3B
$24.1M 0.63%
344,717
-73,883
-18% -$4.95M
BABA icon
39
Alibaba
BABA
$272B
$24M 0.63%
302,288
-5,500
-2% -$430K
DFS
40
DELISTED
Discover Financial Services
DFS
$23.1M 0.6%
431,645
+14,369
+3% +$782K
MRK icon
41
Merck
MRK
$322B
$22.9M 0.59%
415,804
-202,480
-33% -$10.8M
NUE icon
42
Nucor
NUE
$55B
$22.7M 0.59%
459,011
+97,275
+27% +$4.74M
EL icon
43
Estee Lauder
EL
$28.8B
$22.6M 0.59%
248,630
-37,864
-13% -$3.53M
LLY icon
44
Eli Lilly
LLY
$1.06T
$20.7M 0.54%
262,835
+92,712
+54% +$6.98M
DHR icon
45
Danaher
DHR
$134B
$20.2M 0.53%
298,252
-24,146
-7% -$1.58M
KEY icon
46
KeyCorp
KEY
$24.3B
$19.9M 0.52%
1,801,949
-270,669
-13% -$3.23M
CL icon
47
Colgate-Palmolive
CL
$71.7B
$19.4M 0.5%
264,861
+219,459
+483% +$15.6M
BMRN icon
48
BioMarin Pharmaceuticals
BMRN
$11.3B
$19.2M 0.5%
247,100
+38,628
+19% +$3.28M
EMC
49
DELISTED
EMC CORPORATION
EMC
$19.1M 0.5%
704,322
+418,471
+146% +$11.3M
UNH icon
50
UnitedHealth
UNH
$384B
$19M 0.49%
134,775
+27,667
+26% +$3.69M

Similar funds

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.